{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT03963947",
      "orgStudyIdInfo": {
        "id": "MAL-BEL-2018-01"
      },
      "organization": {
        "fullName": "Centro Medico Teknon",
        "class": "OTHER"
      },
      "briefTitle": "Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With House Dust Mites",
      "officialTitle": "Observational Prospective Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With House Dust Mites"
    },
    "statusModule": {
      "statusVerifiedDate": "2023-05",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2019-06-01",
        "type": "ACTUAL"
      },
      "primaryCompletionDateStruct": {
        "date": "2023-05-24",
        "type": "ACTUAL"
      },
      "completionDateStruct": {
        "date": "2023-05-24",
        "type": "ACTUAL"
      },
      "studyFirstSubmitDate": "2019-05-23",
      "studyFirstSubmitQcDate": "2019-05-23",
      "studyFirstPostDateStruct": {
        "date": "2019-05-28",
        "type": "ACTUAL"
      },
      "lastUpdateSubmitDate": "2023-05-24",
      "lastUpdatePostDateStruct": {
        "date": "2023-05-25",
        "type": "ACTUAL"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "SPONSOR_INVESTIGATOR",
        "investigatorFullName": "Alfons Malet i Casajuana",
        "investigatorTitle": "Head of Allergy Service in Teknon Medical Center",
        "investigatorAffiliation": "Centro Medico Teknon"
      },
      "leadSponsor": {
        "name": "Alfons Malet i Casajuana",
        "class": "OTHER"
      },
      "collaborators": [
        {
          "name": "Probelte Pharma S.L.U.",
          "class": "INDUSTRY"
        }
      ]
    },
    "oversightModule": {
      "isFdaRegulatedDrug": false,
      "isFdaRegulatedDevice": false
    },
    "descriptionModule": {
      "briefSummary": "Non-interventional Study to Assess the Safety and Effectiveness Profile of a SCIT Therapy With Beltavac® Polymerised With House Dust Mite in pediatric allergic patients",
      "detailedDescription": "This prospective open multi-center non-interventional study assess the safety and effectiveness profile of the subcutaneous allergen-specific immunotherapy with Beltavac polymerized with house dust mite pediatric allergic patients in routine medical care.\n\nPatients receive a rush schedule administration every month for a year. They attend at least 5 study visits to inform about the adverse reactions, the self reported symptoms and the medication intake."
    },
    "conditionsModule": {
      "conditions": [
        "Rhinoconjunctivitis With or Without Allergic Asthma"
      ]
    },
    "designModule": {
      "studyType": "OBSERVATIONAL",
      "patientRegistry": false,
      "designInfo": {
        "observationalModel": "COHORT",
        "timePerspective": "PROSPECTIVE"
      },
      "bioSpec": {
        "retention": "SAMPLES_WITHOUT_DNA",
        "description": "Serum"
      },
      "enrollmentInfo": {
        "count": 97,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "interventions": [
        {
          "type": "BIOLOGICAL",
          "name": "Beltavac® Polymerized with house dust mites",
          "description": "Adminstration of Beltavac® Polymerized with house dust mites according to the routine clinical practice"
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Numbers of treatment-related local and systemic reactions",
          "timeFrame": "1 Year"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Combined symtom and medication score of Rhinoconjunctivitis",
          "description": "The score will be calculated as a sum of the symptoms score (0-3) and medication score (0-3)",
          "timeFrame": "1 Year"
        },
        {
          "measure": "Combined symtom and medication score of Asthma",
          "description": "The score will be calculated as a sum of the symptoms score (0-3) and medication score (0-3)",
          "timeFrame": "1 Year"
        },
        {
          "measure": "Visual analogue Scale Score",
          "description": "Psycometric scale that assesses the global allergic disease discomfort. It is a 10 cm line representing severity from 0:\"no symptoms\" to 10 \"highest level of symptoms\"",
          "timeFrame": "1 Year"
        },
        {
          "measure": "IgE and IgG4 specific quantification",
          "timeFrame": "1 Year"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients from 3 to 11 years suffering from a clinically relevant Dermatophagoides farinae and Dermatophagoides pteronyssinus induced allergic rhinitis or rhinoconjunctivitis associated with or not with asthma\n* Positive skin testing\n* Positive Serum-Specific IgE determination\n* Parental or legal representative informed consent\n* Clinical sintomatology on the inclusion period\n\nExclusion Criteria:\n\n* Patients suffering from acute or chronic infections or inflammations\n* Patients suffering from uncontrolled and severe asthma\n* Patients with a known autoimmune disease\n* Patients with active malignant disease\n* Patients requiring beta-blockers\n* Patients having any contraindication for the use of adrenaline\n* Patients with previous immunotherapy with this allergen or another allergen with cross-reaction\n* Patients with immunotherapy treatment at the time of inclusion",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "3 Years",
      "maximumAge": "11 Years",
      "stdAges": [
        "CHILD"
      ],
      "studyPopulation": "Patients from 3 to 11 years, who suffer from allergic rhinitis or rhinoconjunctivitis associated with or not with asthma caused by house dust mites",
      "samplingMethod": "NON_PROBABILITY_SAMPLE"
    },
    "contactsLocationsModule": {
      "locations": [
        {
          "facility": "Teknon Medical Center",
          "city": "Barcelona",
          "country": "Spain",
          "geoPoint": {
            "lat": 41.38879,
            "lon": 2.15899
          }
        }
      ]
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    }
  },
  "hasResults": false
}